회원가입 | 연락처 | 사이트맵 | English       회사소개 | 리포트 | 커스텀 리서치 | 고객지원 리포트검색 정보제휴업체

로그인 카테고리 유/무선통신 전기/전자 디지털기기/미디어/방송 Information Technology 에너지 생명공학 화학/신소재 자동차 환경 일반소비재 마케팅/광고 금융 건설 교통/운송 소비자조사 방위/항공/우주 식음료 중공업 교육 기계 무역 스포츠/레저 해운/조선 패션 정부/정책 공예/귀금속 컴퍼니 프로파일 기타산업 무선통신 유선통신 차세대통신 홈네트워크 휴대폰/단말기 RFID IPTV/VoIP 통신융합 통신장비/네트워크 광통신/위성통신 국가별통신시장 기타 전자부품 디스플레이 반도체 조명/LED 로봇 센서 레이저 MEMS Embedded Software SoC 기타 디지털기기/가전 차세대정보기기 휴대용미디어기기 디지털컨텐츠 게임 방송/미디어/엔터테인먼트 STB 기타 e-Commerce e-Learning 보안 소프트웨어/서비스 인터넷 시스템장비 IT기술 기타 태양광발전 신/재생에너지 연료전지 배터리 전기/발전 석유/가스 에너지일반 기타 Digital Health/e-Health 바이오테크놀로지 생체인식 의료장비 제약 진단 헬스케어 기타 나노 신소재/신기술 플라스틱 섬유 폴리머 세라믹 금속/광물 화학 기타 전장 전자부품 텔레메틱스 전기자동차 자동차용품/산업 기타 리사이클 수처리 공기 오염 기타

현재위치 : HOME > 리포트 > 생명공학 > 제약 Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015 발행사 GlobalData 발행일 2015-05 분량 62 pages 서비스형태 Report 판매가격 PDF Single User : $2,500 PDF Department: $5,000 PDF Corporate : $7,500 인쇄하기 Table of Contents Introduction Shigella Infections (Shigellosis) Report Guidance Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Countries Contributing to Clinical Trials in Asia-Pacific Top Countries Contributing to Clinical Trials in Europe Top Countries Contributing to Clinical Trials in North America Top Countries Contributing to Clinical Trials in Middle East and Africa Clinical Trials by G7 Countries: Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials Clinical Trials by Phase in G7 Countries Clinical Trials in G7 Countries by Trial Status Clinical Trials by Phase Clinical Trials by Trial Status Clinical Trials by End Point Status Unaccomplished Trials of Shigella Infections (Shigellosis) Subjects Recruited Over a Period of Time Clinical Trials by Sponsor Type Prominent Sponsors Top Companies Participating in Shigella Infections (Shigellosis) Therapeutics Clinical Trials Prominent Drugs Clinical Trial Profiles Clinical Trial Overview of Top Companies GlaxoSmithKline plc Clinical Trial Overview of GlaxoSmithKline plc Novartis AG Clinical Trial Overview of Novartis AG Icddr,b Clinical Trial Overview of Icddr,b Clinical Trial Overview of Top Institutes / Government Eunice Kennedy Shriver National Institute of Child Health and Human Development Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development University of Maryland Clinical Trial Overview of University of Maryland Institut Pasteur Clinical Trial Overview of Institut Pasteur PATH Clinical Trial Overview of PATH U.S. Army Medical Research and Materiel Command Clinical Trial Overview of U.S. Army Medical Research and Materiel Command U.S. Department of Defense Clinical Trial Overview of U.S. Department of Defense University of Maryland, Baltimore Clinical Trial Overview of University of Maryland, Baltimore University of Oxford Clinical Trial Overview of University of Oxford Five Key Clinical Profiles Appendix Abbreviations Definitions Research Methodology Secondary Research About GlobalData Contact Us Disclaimer Source List of Tables Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Region, 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Europe, Top Countries, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, North America, Top Countries, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Phase, 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Withdrawn Clinical Trials, 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Terminated Clinical Trials, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 Shigella Infections (Shigellosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Icddr,b, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Pasteur, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by PATH, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Defense, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, Baltimore, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015* List of Figures Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Region (%), 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 Shigella Infections (Shigellosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* GlobalData Methodology

회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내
		서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치 대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr Copyright ⓒ 2008 LNH, Inc. All rights reserved.